Figure 3 | Scientific Reports

Figure 3

From: Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects

Figure 3The alternative text for this image may have been generated using AI.

(A) Comparison of in vitro metformin hydrochloride (MH) release curves and mean plasma concentrations in mice 1 and 6 h after administration of G7 and G8 formulations. (B) Metformin (MH) plasma concentrations after single s.c. administration of 100 mg of gel-loaded formulation G8 (MH Gel), or water-soluble preparation (MH Sol) at the same concentration. Plasma levels were determined after 6, 24, and 48 h.

Back to article page